If you could vote on Brexit now which option would you choose?

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

The binding responses and temporal dynamics of antibodies elicited against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) due to vaccination must be fully understood to design future vaccination strategies. A new study published in PLoS ONE characterizes the antibody response to BNT162b2, the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. This study analyzes the temporal dynamics of immunoglobulin G (IgG) and IgM antibody response to five different SARS-CoV-2 epitopes over a period of six months after vaccination.

News-Medical.Net - April 21, 2022

View the full story here: https://www.news-medical.net/news/20220420/Antibody-response-to-Pfizer-BioNTech-COVID-19-vaccine-over-6-months.aspx